title: Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison--comment.
authors.affiliation: Ophthalmology, Agrı Military Hospital, Agrı, Turkey.
authors.forename: Ahmet
authors.initials: A
authors.lastname: Tas
authors.affiliation: Ophthalmology, Sarıkamış Military Hospital, Kars, Turkey.
authors.forename: Umit
authors.initials: U
authors.lastname: Yolcu
authors.affiliation: Ophthalmology, Erzurum Military Hospital, Erzurum, Turkey.
authors.forename: Abdullah
authors.initials: A
authors.lastname: Ilhan
authors.affiliation: Department of Ophthalmology, GATA Medical School, Ankara, Turkey.
authors.forename: Fatih C
authors.initials: FC
authors.lastname: Gundogan
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003907:Dexamethasone / Q000008:administration & dosage*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D008269:Macular Edema / Q000188:drug therapy*; D008297:Male; D012170:Retinal Vein Occlusion / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; D003907:Dexamethasone